Spectralytics, Inc. v. Cordis Corp. (I)

BVLaw
Full Text of Court Cases
September 4, 2009

Access the Full Article

This article and its downloads are available with a subscription to any of these products:
It is also available in this product:
Already a subscriber or product owner?  Login
This article is also available for purchase. (12,049 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
3841 Surgical and Medical Instruments and Apparatus
339112 Surgical and Medical Instrument Manufacturing
intellectual property
Spectralytics, Inc. v. Cordis Corp. (I)
2009 WL 2837358 (D. Minn.)
US
Federal Court
Minnesota
United States District Court
Michael J Timmons
Julie Davis (plaintiff)
Schlitz

Summary

Court upholds $22.5 million patent infringement damages based on 5% reasonable royalty rate, despite defendant’s arguments regarding lack of reliable comparables and evidence that the company sold for only $4 million.
Spectralytics, Inc. v. Cordis Corp. (I)
PDF, Size: 102 KB

See Also

Court Needs to Reread Expert Opinions Before Rendering Damages

Legal and Court Case Update
December 2009

Court upholds $22.5 million patent infringement damages based on 5% reasonable royalty rate, despite defendant’s arguments regarding lack of reliable comparables and evidence that the company sold for only $4 million.

This article also appears in:
Intellectual Property Valuation Case Law Compendium, Fourth Edition